Hyogo collage of Medicine
Nishinomiya, Hyōgo, 665-8501, Japan
NCT Number: NCT02549846
Investigators will study whether immediate statin treatment after the onset of stroke is beneficial on the neurological protection
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Phase 4
Nishinomiya, Hyōgo, 665-8501, Japan
It is much more important in Japan than Western to improve the prognosis after stroke because the prevalence and mortality rate of stroke in Japan is about 3-4 times as those of acute myocardial infarction. Investigators will study whether immediate statin treatment after the onset of stroke is beneficial on the neurological protection since most of previous studies with statins just showed the preventive effects from onset of primary or recurrent cerebral infarction.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Randomized controlled trial of early versus late statin therapy in patients with ischemic stroke
Other names: Atorvastatin, Pitavastain, Rosuvastatin
Time frame: 12 weeks from stroke onset
Scale range from 0 [no symptom] to 6 [dead]
Hyogo Medical University
Other
Randomized Controlled Trial of Early Versus Late Statin Therapy in Patients With Ischemic Stroke
Acronym: ASSORT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05416853
Arterial Occlusive Diseases, Brain Diseases
Hefei, Anhui, China
View Trial DetailsNCT07709806
Brain Diseases, Cardiovascular Diseases
Siping, Jilin, China
View Trial DetailsNCT07654582
Brain Diseases, Cardiovascular Diseases
Cairo, Egypt
View Trial DetailsNCT06049498
Brain Diseases, Cardiovascular Diseases
Beijing, China
View Trial Details